Lung Ambition Alliance

The Lung Ambition Alliance (LAA) is a global coalition currently comprised of three partners, each with distinct and world-leading expertise in lung cancer: AstraZeneca, Guardant Health and the Global Lung Cancer Coalition. The LAA was established in 2019 to accelerate advances in lung cancer survival and improve patient outcomes. We are at a critical moment for the lung cancer community. The disease caused an estimated 1.8 million deaths in 2020 alone, or approximately one-fifth of all deaths from cancer. Without coordinated global action, lung cancer deaths are projected to increase to 3 million by 2040. Our goal is ambitious: to one day eliminate lung cancer as a cause of death. In pursuit of this goal, our focus is three-fold on increasing lung cancer screening and diagnosis; delivering innovative medicines to patients, especially earlier in their care when there is greater potential for cure; and improving quality care through patient advocacy and policymaker collaboration.